A double-blind, randomised, parallel group study has been done comparing the efficacy and tolerability of 7.5 mg/kg ibuprofen syrup (n=77) and 10 mg·kg−1 acetaminophen syrup (n=77) in 154 children (6 months to 5 years) with fever (≥38°C) associated with infectious diseases and treated with antibiotic therapy.
The area under the percentage reduction in temperature curve captured the net effect of each drug and provided the best estimate for comparison of efficacy during a defined period. Temperature evolution over time was not significantly different between the two groups. Nevertheless, the temperature reduction over the first 4 h of treatment (H0–H4) was significantly higher after ibuprofen (60%) than acetaminophen (45%). Both ibuprofen and acetaminophen were well tolerated.
In conclusion, significant antipyretic activity, good tolerability and its availability as a syrup make ibuprofen an effective means of fever control in children.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Arrowsmith JB, Kennedy DL, Kuritsky JN, Faich GA (1987) National patterns of aspirin use and Reye's syndrome reporting. United States, 1980 to 1985. Paediatrics 79: 858–863
Rahwan GL, Rahwan RG (1986) Aspirin an Reye's syndrome: the change in prescribing habits of health professionals. Drug Intell Clin Pharm 20: 143–145
Temple AR (1982) Committee on infectious diseases: aspirin and Reye's syndrome. Paediatrics 69: 810–812
Adams SS, McCullough KF, Nicholson JS (1969) The pharmacological of ibuprofen, an antiinflammatory analgesic and antipyretic agent. Arch Int Pharmacodyn 178: 115–129
Wilson JT (1985) Clinical pharmacology of paediatric antipyretic drugs. Ther Drug Monit 7: 2–11
Walson PB, Galletta G, Braden NJ, Alexander L (1989) Ibuprofen acetaminophen and placebo treatment of febrile children. Clin Pharmacol Ther 46: 9–17
Wilson G, Guerra AJMJ, Santos NT (1984) Comparative study of the antipyretic effect of ibuprofen (oral suspension) and paracetamol (suppositories) in paediatrics. J Int Med Res 12: 250–254
Amdekar YK, Desai BZ (1985) Antipyretic activity of ibuprofen and paracetamol in children with pyrexia. Br J Clin Pract 39: 140–143
Phadke MA, Paranjape PV, Joshi AJ (1985) Ibuprofen in children with infective disorders: antipyretic efficacy. Br J Clin Pact 39: 437–440
Sheth VK, Gupta K, Paul T, Pispati PK (1980) Measurement of antipyretic activity of ibuprofen and paracetamol in children. J Clin Pharmacol 20: 672–675
Simila S, Kouvalainen K, Keinanen S (1976) Oral antipyretic therapy. Evaluation of ibuprofen. Scand J Rheumato 5: 81–83
Heremans G, Dehaen F, Rom N, Ramet J, Verboven M, Loeb H (1988) A single blind parallel group study investigating the antipyretic properties of ibuprofen syrup versus acetylsalicylic acid syrup in febrile children. Br J Clin Pract 41: 245–247
Kandoth PK, Joshi MK, Joshi VR, Satoskar BS (1984) Comparative evaluation of antipyretic activity of ibuprofen and aspirin in children with pyrexia of varied aetiology. J Int Med Res 12: 292–297
Gasperetto P (1974) Un caso di ittero epatocellulare in corso di trattamento con ibuprofen. Minerva Pediatr 26: 531–533
Stempel DA, Miller JJ (1977) Lymphopenia and hepatic toxicity with ibuprofen. J Pediatr 90: 657–658
Biljon F (1989) Reversible renal failure associated with ibuprofen in a child. S Afr Med 76: 34–35
Giannini EH, Brewer EJ, Miller ML, Gibbas D, Passo MH, Hoyerall HM (1990) Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. J Pediatr 117: 645–662
About this article
Cite this article
Autret, E., Breart, G., Jonville, A.P. et al. Comparative efficacy and tolerance of ibuprofen syrup and acetaminophen syrup in children with pyrexia associated with infectious diseases and treated with antibiotics. Eur J Clin Pharmacol 46, 197–201 (1994). https://doi.org/10.1007/BF00192548
- infections disease
- adverse effects